{"id":29734,"date":"2026-01-08T14:24:19","date_gmt":"2026-01-08T13:24:19","guid":{"rendered":"https:\/\/dev8.id-interactive.fr\/new_unither\/?post_type=publication&#038;p=29734"},"modified":"2026-02-03T15:52:10","modified_gmt":"2026-02-03T14:52:10","slug":"webinar-replay-blow-fill-seal-as-a-disruptive-technology-for-the-administration-of-injectable-products","status":"publish","type":"publication","link":"https:\/\/dev8.id-interactive.fr\/new_unither\/publication\/webinar-replay-blow-fill-seal-as-a-disruptive-technology-for-the-administration-of-injectable-products\/","title":{"rendered":"Webinar replay: Blow-Fill-Seal as a disruptive technology for the administration of  injectable products"},"content":{"rendered":"<p><strong>Date<\/strong><br \/>\nSeptember 24<sup>th<\/sup>, 2025<\/p>\n<p><strong>Time<\/strong><br \/>\n11 AM to 11:45 AM (CET)<\/p>\n<p><strong>Topic<\/strong><br \/>\nFrom Formulation to Market: Accelerate Your Injectable Journey with Blow-Fill-Seal<\/p>\n<p><strong>Description<\/strong><\/p>\n<p>This webinar explores how Blow-Fill-Seal (BFS) technology can accelerate the development and delivery of injectable drugs and vaccines \u2014 from early formulation to large-scale distribution. By combining unmatched sterility, flexible formats like Euroject\u00ae, and high cold chain resilience, BFS offers a compelling alternative to pre-filled syringes and multidose vials. You\u2019ll discover Unither\u2019s co-development approach, how it supports biologics and field-ready devices, and what performance data says about BFS under extreme conditions.<\/p>\n<p>Learning outcomes:<\/p>\n<ul class=\"wp-block-list\">\n<li>Understand BFS technology in the context of global vaccine and biologics needs;<\/li>\n<li>Learn how BFS compares to other delivery formats (PFS, multidose) across critical criteria;<\/li>\n<li>Explore real-world BFS applications and data on temperature-sensitive biologics;<\/li>\n<li>Discover the Euroject\u00ae platform and its potential for LMICs;<\/li>\n<li>Learn how Unither supports faster, safer, and leaner product journeys.<\/li>\n<\/ul>\n<p><strong>Speaker<\/strong><\/p>\n<p><strong>Mr. Alexandre Fontayne\u00a0<\/strong><\/p>\n<p>Alexandre Fontayne, PhD, has worked for\u00a0Unither Pharmaceuticals\u00a0as Chief Scientific Officer for biological\u00a0products since 2021 and is deeply involved in the development of the Euroject device. He received his PhD in Biological Science at Universit\u00e9 Paris Sud (Paris, France) and has more than 20 years of experience in research and development, including 13 years at LFB Biotechnology working on drug design and bioproduction of biologics, including ublituximab. Dr Fontayne is co-author of 28 scientific articles and holds 12 patents.<\/p>\n<p>He contributes to the training of students and employees in drug design, chemistry, manufacturing and controls activities and subcontracting.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Date September 24th, 2025 Time 11 AM to 11:45 AM (CET) Topic From Formulation to Market: Accelerate Your Injectable Journey with Blow-Fill-Seal Description This webinar explores how Blow-Fill-Seal (BFS) technology can accelerate the development and delivery of injectable drugs and vaccines \u2014 from early formulation to large-scale distribution. By combining unmatched sterility, flexible formats like [&hellip;]<\/p>\n","protected":false},"featured_media":29736,"menu_order":0,"template":"","meta":{"_acf_changed":false},"topic":[6],"media_type":[14],"class_list":["post-29734","publication","type-publication","status-publish","has-post-thumbnail","hentry","topic-informations","media_type-webinaire"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/publication\/29734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/types\/publication"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/media\/29736"}],"wp:attachment":[{"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/media?parent=29734"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/topic?post=29734"},{"taxonomy":"media_type","embeddable":true,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/media_type?post=29734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}